Baba Ramdev-led Patanjali Ayurved's total income has risen by 23.15 per cent to Rs 9,335.32 crore in 2023-24, helped by other income which includes OFS of Patanjali Foods (earlier known as Ruchi Soya) and income from other group entities, according to RoC filing by the company. In FY24 Patanjali Ayurved's other income was at Rs 2,875.29 crore against Rs 46.18 crore in the year-ago period, according to financial data accessed through business intelligence platform Tofler. Its revenue from operations, which is mainly income from net sales, was down 14.25 per cent to Rs 6,460.03 crore for the financial year ended on March 31, 2024. Revenue was impacted as Patanjali Ayurved transferred its food business to Patanjali Foods on July 1, 2022, which includes biscuits, ghee, cereals, and nutraceuticals. It reported a five-fold jump in its total profit to Rs 2,901.10 crore in FY24. Patanjali Ayurved reported a total profit of Rs 578.44 crore on a revenue of Rs 7,533.88 crore for the financi
The Ruchi Gold oil maker's profit rose to Rs 309 crore (about $37 million) for the three months ended Sept. 30, from Rs 255 crore a year earlier
The Competition Commission of India (CCI) on Tuesday cleared the proposed acquisition of the home and personal care business of Patanjali Ayurved by Patanjali Foods in a Rs 1,100 crore deal. "The proposed combination involves the acquisition of Patanjali Ayurved Ltd's (PAL) Home and Personal Care (HPC) business division (nonfood business) by Patanjali Foods Ltd (PFL)," the CCI said in a release. Patanjali Foods is engaged in processing of oilseeds, refining of crude oil for edible use, production of oil meal, food products from soya and value-added products from downstream and upstream processing. It is also engaged in the business of fast-moving consumer goods, fast moving health goods comprising mainly of food, biscuits and nutraceutical products and engaged in generation of power from wind energy and trading in various products. Patanjali Ayurved is engaged in the business of manufacturing, trading, packing and labelling of ayurvedic medicines, HPC items such as dairy items and
Billionaire Rajiv Jain-backed GQG Partners on Friday hiked its stake in Patanjali Foods by acquiring a 1.24 per cent holding from promoter group entity Patanjali Ayurved Ltd for about Rs 835 crore through an open market transaction. According to the bulk deal data available on the NSE, US-based asset management firm GQG Partners purchased 45.03 lakh shares or 1.24 per cent stake in edible oil major Patanjali Foods. The shares were picked up at an average price of Rs 1,854 apiece, taking the deal value to Rs 834.99 crore. After the latest transaction, GQG Partners' shareholding in Patanjali Foods has increased to 4.43 per cent from 3.19 per cent. Meanwhile, Patanjali Ayurved Ltd on Friday sold 97.92 lakh shares or 2.71 per cent stake in the company for Rs 1,815 crore, the data showed on the National Stock Exchange (NSE). The shares were offloaded at an average price of Rs 1,854.08 per piece, taking the deal value to Rs 1,815.67 crore. After the share sale, the promoter and promote
Patanjali Foods share price: Reports said Promoter entities Patanjali Ayurved, and Patanjali Parivahan were looking to sell up to 11 million shares in the company
The Delhi High Court on Friday sought the Centre's stand on a petition seeking action against the alleged misbranding of Patanjali's "Divya Dant Manjan" as a vegetarian product. The petitioner's counsel claimed that though the dental care product was being sold with a "green dot", symbolising that it was a vegetarian commodity, it contains fish extract, a non-vegetarian ingredient. Justice Sanjeev Narula issued notice to the Centre, the Food Safety and Standards Authority of India (FSSAI) as well as Patanjali, Divya Pharmacy, Yoga guru Ramdev and other related parties on the petition by lawyer Yatin Sharma. The law does not mandate declaration of a "drug" as vegetarian or non-vegetarian but the packaging of "Divya Dant Manjan" wrongly carries a "green dot", which qualifies as "misbranding" under the Drugs and Cosmetics Act, the petitioner's counsel argued. The matter would be heard next in November. Represented by advocates Swapnil Chaudhary and Prashant Gupta, the petitioner stat
'Rule 170 of Drugs and Cosmetic Rules 1945, which deals with prohibition of misleading advertisement of Ayurveda, Siddha or Unani drugs, shall remain in the statute book'
The court, however, warned that both of them must comply with all future orders and not repeat their past conduct
With a strong presence in the hinterland, Patanjali Foods is positive about rural demand moving northwards in the coming quarter.
Licences for 14 Ayurvedic products by Patanjali and Divya Pharmacy were suspended by the Uttarakhand government. However, on July 1, the state government revoked its suspension order
Court says disparaging claims undermine ayurveda's credibility